ALLETE, Inc. (ALE) Misses Q3 EPS by 24c

ALLETE, Inc. (NYSE: ALE) reported Q3 EPS of $0.78, $0.24 worse than the analyst estimate of $1.02. Revenue for the quarter came in at $407.2 million versus the consensus estimate of $390.64 million.

For earnings history and earnings-related data on ALLETE, Inc. (ALE) click here.

You May Also Be Interested In

• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
• e.l.f. Beauty (ELF) PT Raised to $110 at Canaccord
• Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance